Biosafety and Bioethics MCQs (Set-4)

Difficulty: Hard

Before approving environmental release of a modified organism, what should an assessment examine?

A potential persistence, spread, gene flow, and effects on non-target organisms
B only the cost of the culture medium
C only the organism color
D whether a publication is already accepted

A visitor requests access to a restricted biological-material storage room without authorization. This is primarily a

A sequence-quality issue
B gene-expression question
C biosecurity concern
D beneficence concern

A project uses a biological agent at a higher concentration and in a procedure that generates aerosols. Which assumption is appropriate?

A risk may change, so controls and containment should be reassessed
B PPE makes all other controls unnecessary
C the agent name alone fixes every control
D the old assessment remains valid automatically

An autoclave chemical indicator changes color, but biological-indicator validation fails. What should be concluded?

A the load is definitely sterile
B the indicator proves every item is sterile
C the cycle can be ignored if the package is dry
D the sterilization process is not confirmed effective

A genomic data repository removes names but keeps a detailed phenotype and rare-variant combination. What risk remains?

A only a sequence-alignment risk
B re-identification from linked or unique data features
C loss of base-call quality
D no risk because names are absent

A participant agrees to one study but not future sharing of identifiable genome data. Which action respects autonomy?

A share the data because the original study was approved
B assume consent for one study covers all future uses
C limit reuse to the consented scope or seek appropriate additional permission and review
D publish the participant identity

A genome analysis may reveal a medically relevant finding, but the participant chose not to receive incidental results. What should the research team do?

A post the result in a public database with identity
B send every raw result regardless of preference
C follow the disclosed return-of-results policy and the participant preference
D ignore the consent record

A community contributes samples and asks how benefits will be shared. What is a responsible next step?

A release individual-level data publicly
B avoid documenting the discussion
C engage the community and clarify governance and benefit-sharing arrangements
D promise all benefits without a plan

A researcher discovers that a coauthor altered image data without documentation. What is the appropriate response?

A wait until the paper is cited
B preserve original records and report through research-integrity procedures
C delete the original images
D edit other results to match

A study has a strong scientific purpose but includes avoidable risk with no added value. What is the best ethical response?

A rely on consent to justify any risk
B redesign to reduce or remove unnecessary risk before approval
C hide the risk in technical wording
D increase enrollment to dilute the risk

A biosafety committee is reviewing work with a modified organism whose survival outside the lab is uncertain. What should it request?

A a guarantee that release cannot occur
B evidence and controls addressing persistence, dispersal, and environmental consequences
C the final journal citation only
D only the organism name

A project changes from a non-pathogenic host to a host with different survival traits. What is needed?

A keep the prior risk rating automatically
B use only the same gloves
C skip biosafety review because the DNA is unchanged
D reassess environmental persistence and containment needs

A laboratory uses a biological safety cabinet but blocks its airflow grilles with supplies. What is the main concern?

A the cabinet will sterilize the supplies
B the sample will become a genome assembly
C airflow and containment performance may be compromised
D the room will become chemical-free

A clean work area is prepared inside a cabinet, but the cabinet has not been certified. What is the issue?

A the cabinet becomes a fume hood
B the required containment performance is unverified
C certification only affects sample labeling
D the work is automatically safe because the area looks clean

A project releases a modified organism outside a contained facility. Which decision process is necessary?

A skip monitoring because the organism is modified
B follow applicable approval and environmental-risk assessment requirements before release
C release it first and assess later
D use only the lab’s internal label

A biosafety incident has no injury, but a containment breach occurred. Should it be reported?

A no, only events with injury matter
B only if the media ask
C after the experiment is published
D yes, near misses and breaches should be reported under local procedures

A human-subject study is scientifically strong but has risks that are not justified by its expected benefits. What should the ethics review conclude?

A the balance of risks and benefits is ethically unacceptable unless redesigned
B the risks should be hidden from participants
C consent removes every ethical concern
D scientific quality alone makes it acceptable

A genomic dataset is shared openly to support research. What safeguards should be considered first?

A consent scope, re-identification risk, access conditions, and benefit sharing
B only file format
C whether the paper is already published
D whether the sequence is long

A research group wants to use animals because an alternative method is less convenient. Which question should be asked?

A can the protocol avoid ethics review?
B is the animal easy to obtain?
C will the study finish faster?
D can a validated non-animal method answer the scientific question?

A proposed animal experiment has weak statistical design and an unnecessarily large sample. What should be revised?

A the design and sample-size justification before approval
B the publication title
C the data after collection
D only the animal housing label

A participant’s consent is obtained through technical language they cannot understand. What is deficient?

A sequence annotation
B sample quality control
C biosecurity
D meaningful informed choice

A study stores identifiable genome data in an unencrypted shared folder. What is the primary concern?

A low query coverage
B incorrect read mapping
C lack of a biological safety cabinet
D unauthorized disclosure of sensitive information

A study’s likely benefits will be shared with one country, while samples come from another with no involvement in governance. What principle should be considered?

A equity and fair benefit sharing
B sequence identity
C contig N50
D Phred quality

A researcher is asked to remove an inconvenient result from a report. Which action is ethically sound?

A delete it without documentation
B publish only favorable data
C retain accurate results and transparently describe exclusions or limitations
D change the result to fit the hypothesis

A laboratory develops a new procedure that changes aerosol risk. Which action best maintains a strong biosafety program?

A wait for an incident before changing anything
B continue under the old procedure without review
C remove the risk assessment record
D update the risk assessment, SOP, training, and controls